NASDAQ
Aida Pharmaceuticals, Inc. (AIDA) has a price/sales ratio of 1.04x as of Friday, May 22, 2026. This represents a 22.89% decrease compared to its 12-month average of 1.35x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.